Research areas

researches

ENDOCRINOLOGY. DIABETES MELLITUS TYPE II

Assessment of the safety and efficacy of the use of cultured autologous (allogenic) multipotent mesenchymal stromal cells from adipose tissue in patients with type 2 diabetes mellitus.

NEUROLOGY. SPINE AND SPINAL CORD INJURIES

Assessment of the safety and efficacy of the use of neural crest-derived cells (NC-MSCs) in patients with the effects of spinal cord injury.

DERMATOLOGY. AGE-RELATED CHANGES IN SKIN

Evaluation of the safety and efficacy of the medical product containing cultured autologous fibroblasts in patients with age-related changes and/or scar tissue defects of facial skin.

REPRODUCTOLOGY. FEMALE INFERTILITY

Cellular therapy of female infertility of the uterine genesis against the background of endometrial hypoplasia.

COMBUSTIOLOGY

Evaluation of the safety and efficacy of cultured multipotent mesenchymal stromal cells from human adipose tissue in the treatment of burn wounds.

PURULENT SURGERY. CHRONIC WOUNDS

Evaluation of the safety and efficacy of cultured multipotent mesenchymal stromal cells from human adipose tissue in the treatment of purulent wounds.

NEUROLOGY. Intervertebral discs herniation

Evaluation of the safety and efficacy of the application of cultured autologous and allogenic multipotent mesenchymal stromal cells in patients with neurocompression syndrome due to herniated nucleus pulposus.

TRAUMATOLOGY. BONE TISSUE DEFECTS

Evaluation of the safety and efficacy of transplantation of cultured autologous multipotent mesenchymal stromal cells from bone marrow in patients with prolonged bone fracture healing and in patients with traumatic bone tissue defects.

Neurology. Multiple sclerosis

Evalution of the safety and efficacy of the medical product of cultured autoimmune neural crest derivatives (NCDs) in patients with remitting multiple sclerosis.